OP 10
Bendamustine-bortezomib-dexamethasone (BVD) in heavily pretreated multiple myeloma: old/new in novel agents’ era
Lido
2042
Vezesque se leu este artigo
1016
Total PDF
1026
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 16 | 8 | 24 |
| 2025 5 | 59 | 14 | 73 |
| 2025 4 | 33 | 13 | 46 |
| 2025 3 | 49 | 11 | 60 |
| 2025 2 | 33 | 18 | 51 |
| 2025 1 | 32 | 22 | 54 |
| 2024 12 | 18 | 11 | 29 |
| 2024 11 | 31 | 14 | 45 |
| 2024 10 | 20 | 15 | 35 |
| 2024 9 | 27 | 21 | 48 |
| 2024 8 | 18 | 30 | 48 |
| 2024 7 | 12 | 15 | 27 |
| 2024 6 | 16 | 27 | 43 |
| 2024 5 | 24 | 21 | 45 |
| 2024 4 | 15 | 18 | 33 |
| 2024 3 | 17 | 21 | 38 |
| 2024 2 | 24 | 20 | 44 |
| 2024 1 | 16 | 27 | 43 |
| 2023 12 | 20 | 23 | 43 |
| 2023 11 | 42 | 36 | 78 |
| 2023 10 | 11 | 16 | 27 |
| 2023 9 | 16 | 30 | 46 |
| 2023 8 | 23 | 18 | 41 |
| 2023 7 | 13 | 6 | 19 |
| 2023 6 | 19 | 18 | 37 |
| 2023 5 | 19 | 13 | 32 |
| 2023 4 | 14 | 2 | 16 |
| 2023 3 | 12 | 16 | 28 |
| 2023 2 | 8 | 7 | 15 |
| 2023 1 | 13 | 9 | 22 |
| 2022 12 | 10 | 17 | 27 |
| 2022 11 | 13 | 11 | 24 |
| 2022 10 | 14 | 18 | 32 |
| 2022 9 | 13 | 21 | 34 |
| 2022 8 | 11 | 19 | 30 |
| 2022 7 | 13 | 26 | 39 |
| 2022 6 | 7 | 16 | 23 |
| 2022 5 | 9 | 17 | 26 |
| 2022 4 | 19 | 24 | 43 |
| 2022 3 | 16 | 13 | 29 |
| 2022 2 | 15 | 20 | 35 |
| 2021 1 | 13 | 12 | 25 |
| 2021 12 | 12 | 18 | 30 |
| 2021 11 | 13 | 19 | 32 |
| 2021 10 | 21 | 25 | 46 |
| 2021 9 | 14 | 16 | 30 |
| 2021 8 | 11 | 22 | 33 |
| 2021 7 | 14 | 18 | 32 |
| 2021 6 | 14 | 22 | 36 |
| 2021 5 | 23 | 26 | 49 |
| 2021 4 | 24 | 39 | 63 |
| 2021 3 | 19 | 27 | 46 |
| 2021 2 | 11 | 17 | 28 |
| 2020 1 | 14 | 13 | 27 |
| 2020 12 | 7 | 9 | 16 |
| 2020 11 | 6 | 11 | 17 |
Mostrar tudo
